|
1）平成23年（2011）人口動態統計（確定数）の概況 厚生労働省 統計情報・白書厚生労働省HP: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei11/
|
|
|
|
|
2）厚生労働省大臣官房統計情報部: 昭和50年～平成21年人口動態統計
|
|
|
|
|
|
3）田中純子．肝癌の疫学と対策．内科 特集 肝癌診療の最前線．2012; 109(3): 386-692
|
|
|
|
|
|
4）日本肝癌研究会: 第5回～第18回全国原発性肝癌追跡調査報告．日本肝癌研究会事務局．1982-2009
|
|
|
|
|
|
5）Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res. 2012; 42(1): 1-14
|
|
|
|
|
6）Okanoue T, Umemura A, Yasui K, et al. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol. 2011; 26 Suppl 1: 153-62. doi: 10.1111/j.1440-1746.2010.06547.x
|
|
|
|
|
|
7）Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am. 2010; 24(4): 899-919
|
|
|
|
|
|
8）Tokushige K, Hashimoto E, Horie Y, et al. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol. 2011; 46(10): 1230-7
|
|
|
|
|
|
9）El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142(6): 1264-73
|
|
|
|
|
|
10）International Agency for Research on Can-cer(IARC), Liver cancer incidence, mortality and prevalence worldwide in 2008. Lyon: GLO-BOCAN; 2008.
|
|
|
|
|
|
11）独立行政法人国立がん研究センター「がん対策情報センター癌情報サービス」最新がん統計http://ganjoho.jp/public/statistics/pub/statistics01.html
|
|
|
|
|
|
12）Wild CP. The role of cancer research in noncommunicable disease control. J Natl Cancer Inst. 2012; 104(14): 1051-8
|
|
|
|
|
|
13）Tangutur NK, Medvedev SF, Regenstein F, et al. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009. J La State Med Soc. 2011; 163(4): 185-90
|
|
|
|
|
|
14）Sherman M. Epidemiology of hepatocellular carcinoma. Oncology. 2010; 78 Suppl 1: 7-10
|
|
|
|
|
|
15）Witjes CD, Karim-Kos HE, Visser O, et al. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival. Eur J Gastroenterol Hepatol. 2012; 24(4): 450-7
|
|
|
|
|
|
16）Tanaka J, Koyama T, Mizui M, et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirology. 2011; 54(4): 185-95
|
|
|
|
|
|
17）田中純子．平成23年度 厚生労働科学研究費補助金 肝炎等克服緊急対策研究事業 肝炎ウイルス感染状況・長期経過と予後調査及び治療導入対策に関する研究，総括研究報告書．2012; p.1-29
|
|
|
|
|
|
18）Ly KN, Xing J, Klevens RM, et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012; 156(4): 271-8
|
|
|
|
|
|
19）CDC. Viral hepatitis surveillance, United States, 2009-2011. Available at http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/index.htm. Accessed June 18, 2012
|
|
|
|
|
|
20）Smith BD, Patel N, Beckett GA, et al. Hepatitis C virus antibodyprevalence, correlates and predictors among persons born from 1945 through 1965, United States, 1999–2008. American Association for the Study of Liver Disease; 2011
|
|
|
|
|
|
21）CDC. Viral hepatitis: statistics and surveillance, 2009. Available at: http://www.cdc.gov/hepatitis/Statistics.htm. Accessed 19 May 2011
|
|
|
|
|
|
22）Kim WR, Terrault NA, Pedersen RA, et al. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology. 2009; 137(5): 1680-6
|
|
|
|
|
|
23）Spradling PR, Rupp L, Moorman AC, et al. Hepatitis B and C virus infection among 1.2 million persons with access to care: Factors associated with testing and infection prevalence. Clin Infect Dis. 2012; 55(8): 1047-55
|
|
|
|
|
|
24）Smith BD, Morgan RL, Beckett GA, et al. Centers for disease control and prevention recommenda-tions for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.MMWR Recomm Rep. 2012; 61(RR-4): 1-32
|
|
|
|
|
|
25）World Health Organitation Fact Sheet. July 2012
|
|
|
|
|
|
26）El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo,Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009. Available at http://www.measuredhs.com/pubs/pdf/fr220/fr220
|
|
|
|
|
|
27）MacroInternational; 2009. Available at http://www.measuredhs.com/pubs/pdf/fr220/fr220.
|
|
|
|
|
|
28）Centers for Disease Control and Prevention (CDC). Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012. MMWR Morb Mortal Wkly Rep. 2012; 61(29): 545-9
|
|
|
|
|
|
29）Paez Jimenez A, Mohamed MK, Sharaf Eldin N, et al. Injection drug. use is a risk factor for HCV infection in urban Egypt. PloS One 2009; 4: e7193
|
|
|
|
|
|
30）Mostafa A, Taylor S, El-Daly M, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int. 2010; 31: 560–6
|
|
|
|
|